OPTN/SRTR 2019 Annual Data Report: Liver
- PMID: 33595192
- DOI: 10.1111/ajt.16494
OPTN/SRTR 2019 Annual Data Report: Liver
Abstract
This year was notable for changes to exception points determined by the geographic median allocation Model for End-Stage Liver Disease (MELD) and implementation of the National Liver Review Board, which took place on May 14, 2019. The national acuity circle liver distribution policy was also implemented but reverted to donor service area- and region-based boundaries after 1 week. In 2019, growth continued in the number of new waiting list registrations (12,767) and transplants performed (8,896), including living-donor transplants (524). Compared with 2018, living-donor liver transplants increased 31%. Women continued to have a lower deceased-donor transplant rate and a higher pretransplant mortality rate than men. The median waiting time for candidates with a MELD of 15-34 decreased, while the number of transplants performed for patients with exception points decreased. These changes may have been related to the policy changes that took effect in May 2019, which increased waiting list priority for candidates without exception status. Hepatitis C continued to decline as an indication for liver transplant, as the proportion of liver transplant recipients with alcohol-related liver disease and clinical profiles consistent with non-alcoholic steatohepatitis increased. Graft and patient survival have improved despite changing recipient demographics including older age, higher MELD, and higher prevalence of obesity and diabetes.
Keywords: Liver transplant; allocation; distribution; waiting list.
.
Similar articles
-
OPTN/SRTR 2022 Annual Data Report: Liver.Am J Transplant. 2024 Feb;24(2S1):S176-S265. doi: 10.1016/j.ajt.2024.01.014. Am J Transplant. 2024. PMID: 38431359
-
OPTN/SRTR 2021 Annual Data Report: Liver.Am J Transplant. 2023 Feb;23(2 Suppl 1):S178-S263. doi: 10.1016/j.ajt.2023.02.006. Am J Transplant. 2023. PMID: 37132348
-
OPTN/SRTR 2017 Annual Data Report: Liver.Am J Transplant. 2019 Feb;19 Suppl 2:184-283. doi: 10.1111/ajt.15276. Am J Transplant. 2019. PMID: 30811890
-
OPTN/SRTR 2018 Annual Data Report: Liver.Am J Transplant. 2020 Jan;20 Suppl s1:193-299. doi: 10.1111/ajt.15674. Am J Transplant. 2020. PMID: 31898413 Review.
-
OPTN/SRTR 2018 Annual Data Report: Kidney.Am J Transplant. 2020 Jan;20 Suppl s1:20-130. doi: 10.1111/ajt.15672. Am J Transplant. 2020. PMID: 31898417 Review.
Cited by
-
Biofabrication of synthetic human liver tissue with advanced programmable functions.iScience. 2022 Nov 4;25(12):105503. doi: 10.1016/j.isci.2022.105503. eCollection 2022 Dec 22. iScience. 2022. PMID: 36404924 Free PMC article.
-
Impact of DSA and immunosuppression minimization on rejection, graft, and patient survival after simultaneous liver-kidney transplantation.Front Med (Lausanne). 2022 Aug 22;9:949833. doi: 10.3389/fmed.2022.949833. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36072942 Free PMC article.
-
Maximizing utility of nondirected living liver donor grafts using machine learning.Front Immunol. 2023 Jun 29;14:1194338. doi: 10.3389/fimmu.2023.1194338. eCollection 2023. Front Immunol. 2023. PMID: 37457719 Free PMC article.
-
Waiting time dictates impact of frailty: A Spanish multicenter prospective study.JHEP Rep. 2023 Jul 12;5(11):100840. doi: 10.1016/j.jhepr.2023.100840. eCollection 2023 Nov. JHEP Rep. 2023. PMID: 37767462 Free PMC article.
-
Evolution of Liver Transplantation Indications: Expanding Horizons.Medicina (Kaunas). 2024 Feb 28;60(3):412. doi: 10.3390/medicina60030412. Medicina (Kaunas). 2024. PMID: 38541138 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical